Top

Published in:

01-05-2018 | Original Article

Thinking about one’s own death after prostate-cancer diagnosis

Authors: Thordis K. Thorsteinsdottir, Heiddis Valdimarsdottir, Johan Stranne, Ulrica Wilderäng, Eva Haglind, Gunnar Steineck

Published in: Supportive Care in Cancer | Issue 5/2018

Abstract

Background

Prostate-cancer diagnosis increases the risk for psychiatric morbidity and suicide. Thoughts about one’s own death could indicate need for psychiatric care among men with localized prostate cancer. We studied the prevalence and predictors of thoughts about own death among men with prostate cancer.

Methods

Of the 3930 men in the prospective, multi-centre LAPPRO-trial, having radical prostatectomy, 3154 (80%) answered two study-specific questionnaires, before and three months after surgery. Multivariable prognostic models were built with stepwise regression and Bayesian Model Averaging.

Results

After surgery 46% had thoughts about their own death. Extra-prostatic tumor-growth [Adjusted Odds-Ratio 2.06, 95% Confidence Interval 1.66–2.56], university education [OR 1.66, CI 1.35–2.05], uncertainty [OR 2.20, CI 1.73–2.82], low control [OR 2.21, CI 1.68–2.91], loneliness [OR 1.75, CI 1.30–2.35], being a burden [OR 1.59, CI 1.23–2.07], and crying [OR 1.55, CI 1.23–1.96] before surgery predicted thoughts about one’s own death after surgery.

Conclusions

We identified predictors for thoughts about one’s own death after prostate cancer diagnosis and surgery. These factors may facilitate the identification of psychiatric morbidity and those who might benefit from psychosocial support already during primary treatment.

Available only for authorised users

Bill-Axelson A, Garmo H, Lambe M, Bratt O, Adolfsson J, Nyberg U, Steineck G, Stattin P (2010) Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe. Sweden European Urology 57(3):390–395. https://doi.org/10.1016/j.eururo.2009.10.035 CrossRefPubMed

Fall K, Fang F, Mucci LA, Ye W, Andrén O, Johansson J-E, Andersson S-O, Sparén P, Klein G, Stampfer M, Adami H-O, Valdimarsdottir U (2009) Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Med 6(12):e1000197. https://doi.org/10.1371/journal.pmed.1000197 CrossRefPubMedPubMedCentral

Fang F, Fall K, Mittleman MA, Sparen P, Ye W, Adami H-O, Valdimarsdottir U (2012) Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med 366(14):1310–1318. https://doi.org/10.1056/NEJMoa1110307 CrossRefPubMed

Fang F, Keating NL, Mucci LA, Adami H-O, Stampfer MJ, Valdimarsdottir U, Fall K (2010) Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst 102(5):307–314. https://doi.org/10.1093/jnci/djp537 CrossRefPubMed

Llorente MD, Burke M, Gregory GR, Bosworth HB, Grambow SC, Horner RD, Golden A, Olsen EJ (2005) Prostate cancer: a significant risk factor for late-life suicide American. Journal of Geriatric Psychiatry 13(3):195–201. https://doi.org/10.1097/00019442-200503000-00004 CrossRef

Jonsson A, Aus G, Bertero C (2010) Living with a prostate cancer diagnosis: a qualitative 2-year follow-up. The Aging Male 13(1):25–31. https://doi.org/10.3109/13685530903424170 CrossRefPubMed

Kelly D (2009) Changed men: the embodied impact of prostate cancer qualitative. Health research 19:151–163

Westman B, Bergenmar M, Andersson L (2006) Life, illness and death - existential reflections of a Swedish sample of patients who have undergone curative treatment for breast or prostatic cancer. Eur J Oncol Nurs 10(3):169–176. https://doi.org/10.1016/j.ejon.2005.06.002 CrossRefPubMed

Bisson JI, Chubb HL, Bennett S, Mason M, Jones D, Kynaston H (2002) The prevalence and predictors of psychological distress in patients with early localized prostate cancer. BJU Int 90(1):56–61. https://doi.org/10.1046/j.1464-410X.2002.02806.x CrossRefPubMed

10.

Thorsteinsdottir T, Hedelin M, Stranne J, Valdimarsdottir H, Wilderang U, Haglind E, Steineck G (2013) Intrusive thoughts and quality of life among men with prostate cancer before and three months after surgery. Health Qual Life Outcomes 11(1):154. https://doi.org/10.1186/1477-7525-11-154 CrossRefPubMedPubMedCentral

11.

Thorsteinsdottir T, Valdimarsdottir H, Hauksdottir A, Stranne J, Wilderäng U, Haglind E, Steineck G (2017) Care-related predictors for negative intrusive thoughts after prostate cancer diagnosis—data from the prospective LAPPRO trial. Psycho-Oncology 26(11):1749–1757. https://doi.org/10.1002/pon.4359

12.

Thorsteinsdottir T, Stranne J, Carlsson S, Anderberg B, Bjorholt I, Damber J-E, Hugosson J, Wilderang U, Wiklund P, Steineck G, Haglind E (2011) LAPPRO: a prospective multicentre comparative study of robot-assisted laparoscopic and retropubic radical prostatectomy for prostate cancer Scandinavian. Journal of Urology and Nephrology 45:102–112

13.

Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, Nordling S, Haggman M, Andersson SO, Spangberg A, Andren O, Palmgren J, Steineck G, Adami HO, Johansson JE (2014) Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 370(10):932–942. https://doi.org/10.1056/NEJMoa1311593 CrossRefPubMedPubMedCentral

14.

Enblom A, Johnsson A, Hammar M, Onelov E, Steineck G, Borjeson S (2012) Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea--a randomized controlled study. Ann Oncol 23(5):1353–1361. https://doi.org/10.1093/annonc/mdr402 CrossRefPubMed

15.

Kreicbergs U, Valdimarsdottir U, Onelov E, Henter JI, Steineck G (2004) Talking about death with children who have severe malignant disease. N Engl J Med 351(12):1175–1186. https://doi.org/10.1056/NEJMoa040366 CrossRefPubMed

16.

Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlen BJ, Holmberg L (2002) Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347(11):790–796. https://doi.org/10.1056/NEJMoa021483 CrossRefPubMed

17.

Steineck G, Bergmark K, Henningsohn L, Al-Abany M, Dickman PW, Helgason A (2002) Symptom documentation in cancer survivors as a basis for therapy modifications. Acta Oncol 41(3):244–252. https://doi.org/10.1080/02841860260088782 CrossRefPubMed

18.

Lind H, Waldenstrom AC, Dunberger G, Al-Abany M, Alevronta E, Johansson KA, Olsson C, Nyberg T, Wilderang U, Steineck G, Avall-Lundqvist E (2011) Late symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study. Brit J Cancer 105(6):737–745. https://doi.org/10.1038/bjc.2011.315 CrossRefPubMedPubMedCentral

19.

Bursac Z, Gauss CH, Williams DK, Hosmer DW (2008) Purposeful selection of variables in logistic regression. Source Code Biol Med 3(1):17. https://doi.org/10.1186/1751-0473-3-17 CrossRefPubMedPubMedCentral

20.

Genell A, Nemes S, Steineck G, Dickman PW (2010) Model selection in medical research: a simulation study comparing Bayesian model averaging and stepwise regression. BMC Med Res Methodol 10(1):108. https://doi.org/10.1186/1471-2288-10-108 CrossRefPubMedPubMedCentral

21.

Kass RE, Raftery AE (1995) Bayes factors. J Am Stat Assoc 90(430):773–795. https://doi.org/10.1080/01621459.1995.10476572 CrossRef

22.

Development Core Team R (2005) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna

23.

Sobin L, Gospodarowicz MK, Wittekind C (2010) TNM classification of malignant Tumours. In: Editor (ed) Book TNM classification of malignant Tumours. Wiley, Blackwell City, p 256

24.

Lepore SJ, Helgeson VS (1998) Social constraints, intrusive thoughts, and mental health after prostate cancer. J Soc Clin Psychol 17(1):89–106. https://doi.org/10.1521/jscp.1998.17.1.89 CrossRef

25.

Walker J, Waters RA, Murray G, Swanson H, Hibberd CJ, Rush RW, Storey DJ, Strong VA, Fallon MT, Wall LR, Sharpe M (2008) Better off dead: suicidal thoughts in cancer patients. J Clin Oncol 26(29):4725–4730. https://doi.org/10.1200/JCO.2007.11.8844 CrossRefPubMed

26.

Walker J, Hansen CH, Butcher I, Sharma N, Wall L, Murray G, Sharpe M (2011) Thoughts of death and suicide reported by cancer patients who endorsed the “suicidal thoughts” item of the PHQ-9 during routine screening for depression. Psychosomatics 52(5):424–427. https://doi.org/10.1016/j.psym.2011.02.003 CrossRefPubMed

27.

Walker J, Hansen CH, Hodges L, Thekkumpurath P, O'Connor M, Sharma N, Kleiboer A, Murray G, Kroenke K, Sharpe M (2010) Screening for suicidality in cancer patients using item 9 of the nine-item patient health questionnaire; does the item score predict who requires further assessment? Gen Hosp Psychiatry 32(2):218–220. https://doi.org/10.1016/j.genhosppsych.2009.11.011 CrossRefPubMed

28.

Sunny L, Hopfgarten T, Adolfsson J, Steineck G (2007) Economic conditions and marriage quality of men with prostate cancer. British Journal of Urology International 99(6):1391–1397. https://doi.org/10.1111/j.1464-410X.2007.06807.x CrossRef

29.

Sharpley CF, Christie DH, Bitsika V, Oar AJ (2013) The effects of low- and high-dose-rate brachytherapy on depressive symptoms in prostate cancer patients. Int J Clin Oncol 19(6):1080–1084. https://doi.org/10.1007/s10147-013-0647-1

30.

Cacioppo JT, Hawkley LC, Thisted RA (2010) Perceived social isolation makes me sad: 5-year cross-lagged analyses of loneliness and depressive symptomatology in the Chicago health, aging, and social relations. Study Psychol Aging 25(2):453–463. https://doi.org/10.1037/a0017216 CrossRefPubMed

31.

Helgason AR, Dickman PW, Adolfsson J, Steineck G (2001) Emotional isolation: prevalence and the effect on well-being among 50-80-year-old prostate cancer patients. Scand J Urol Nephrol 35(2):97–101CrossRefPubMed

32.

Steineck G, Hunt H, Adolfsson J (2006) A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods. Acta oncologica (Stockholm, Sweden) 45(4):421–429. https://doi.org/10.1080/02841860600649293 CrossRef

33.

Litwin MS, Lubeck DP, Henning JM, Carroll PR (1998) Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database. J Urol 159(6):1988–1992. https://doi.org/10.1016/S0022-5347(01)63222-1 CrossRefPubMed

34.

Månsson A, Henningsohn L, Steineck G, Månsson W (2004) Neutral third party versus treating institution for evaluating quality of life after radical cystectomy. Eurpean Urology 46(2):195–199. https://doi.org/10.1016/j.eururo.2004.04.010 CrossRef

35.

Skoogh J, Steineck G, Johansson B, Wilderang U, Stierner U (2013) Psychological needs when diagnosed with testicular cancer: findings from a population-based study with long-term follow-up. BJU Int 111(8):1287–1293. https://doi.org/10.1111/j.1464-410X.2012.11696.x CrossRefPubMed

36.

Stinesen-Kollberg K, Thorsteinsdottir T, Wilderang U, Steineck G (2013) Worry about one's own children, psychological well-being, and interest in psychosocial intervention. Psycho-Oncology 22(9):2117–2123. https://doi.org/10.1002/pon.3266 CrossRefPubMed

37.

Skoogh J, Ylitalo N, Larsson Omerov P, Hauksdottir A, Nyberg U, Wilderang U, Johansson B, Gatz M, Steineck G (2010) ‘A no means no’--measuring depression using a single-item question versus hospital anxiety and depression scale (HADS-D). Ann Oncol 21(9):1905–1909. https://doi.org/10.1093/annonc/mdq058 CrossRefPubMed

Title: Thinking about one’s own death after prostate-cancer diagnosis
Authors: Thordis K. Thorsteinsdottir
Heiddis Valdimarsdottir
Johan Stranne
Ulrica Wilderäng
Eva Haglind
Gunnar Steineck
Publication date: 01-05-2018
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 5/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-017-3986-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2018

The impact of palliative care training for oncologists and integrative palliative service in a public-funded hospital cluster—a retrospective cohort study

Information needs of adolescent and young adult cancer patients and their parent-carers

Accuracy of cystatin C for the detection of abnormal renal function in children undergoing chemotherapy for malignancy: a systematic review using individual patient data

Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy

Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy

Prevalence and correlates of high fear of cancer recurrence in late adolescents and young adults consulting a specialist adolescent and young adult (AYA) cancer service

Keynote webinar | Spotlight on antibody–drug conjugates in cancer